[1-Phenyl-meth-(E)-ylidene]-(2-thiophen-2-yl-ethyl)-amine | 213462-06-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: [1-Phenyl-meth-(E)-ylidene]-(2-thiophen-2-yl-ethyl)-amine
• 英文别名: 1-phenyl-N-(2-thiophen-2-ylethyl)methanimine
• CAS: 213462-06-7
• 化学式: C₁₃H₁₃NS
• 分子量: 215.319
• InChiKey: WMYISDCBMGJGMJ-UHFFFAOYSA-N

物化性质

• 沸点：
  338.8±25.0 °C(Predicted)
• 密度：
  1.05±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  15
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.15
• 拓扑面积：
  40.6
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  [1-Phenyl-meth-(E)-ylidene]-(2-thiophen-2-yl-ethyl)-amine 在 三氟乙酸 作用下， 反应 72.0h， 以0.823 g的产率得到4-苯基-4,5,6,7-四氢噻吩并[3,2-c]吡啶
  参考文献：
  名称：

  葡萄糖-6-磷酸酶催化酶抑制剂：新型4,5,6,7-四氢噻吩并[3,2-c]-和-[2,3-c]吡啶的合成及体外评估。

  摘要：

  描述了发现第一类有效的葡萄糖-6-磷酸酶催化位点抑制剂，即取代的4,5,6,7-四氢噻吩并[3,2-c]-和-[2,3-c]吡啶。该系列的优化涉及溶液相组合合成，并且制备的强效化合物的IC50值低至140 nM。这些化合物的结构活性关系（SAR）表明：四氢噻吩并[3,2-c]吡啶核环系统和异构体[2,3-c]系统是等位的，并且比相应的苯并类似物好得多，1 2,3,4-四氢异喹啉。四氢噻吩并[3，2-c]吡啶环的4-取代基必须是苯基，任选被亲脂性4-取代基如三氟甲氧基或氯取代。四氢噻吩并[3，2-c]吡啶环的5-取代基必须是取代的苯甲酰基；异戊基和（E）-3-呋喃-3-基丙烯酰基是所研究的最佳基团。似乎禁止在苯甲酰基邻位取代，而仅当存在甲氧基对位取代基时才容许在间位取代。这些SAR结果与在4,5,6,7-四氢噻吩并[2,3-c]吡啶系统中获得的结果相似。在酶识别中观察到对映选择性，并且该活性仅在一种对映异构体中存在于所有情况下。

  DOI：

  10.1016/s0968-0896(00)00153-x
• 作为产物：
  描述：

  噻吩乙胺 、 苯甲醛 以 甲苯 为溶剂， 生成 [1-Phenyl-meth-(E)-ylidene]-(2-thiophen-2-yl-ethyl)-amine
  参考文献：
  名称：

  葡萄糖-6-磷酸酶催化酶抑制剂：新型4,5,6,7-四氢噻吩并[3,2-c]-和-[2,3-c]吡啶的合成及体外评估。

  摘要：

  描述了发现第一类有效的葡萄糖-6-磷酸酶催化位点抑制剂，即取代的4,5,6,7-四氢噻吩并[3,2-c]-和-[2,3-c]吡啶。该系列的优化涉及溶液相组合合成，并且制备的强效化合物的IC50值低至140 nM。这些化合物的结构活性关系（SAR）表明：四氢噻吩并[3,2-c]吡啶核环系统和异构体[2,3-c]系统是等位的，并且比相应的苯并类似物好得多，1 2,3,4-四氢异喹啉。四氢噻吩并[3，2-c]吡啶环的4-取代基必须是苯基，任选被亲脂性4-取代基如三氟甲氧基或氯取代。四氢噻吩并[3，2-c]吡啶环的5-取代基必须是取代的苯甲酰基；异戊基和（E）-3-呋喃-3-基丙烯酰基是所研究的最佳基团。似乎禁止在苯甲酰基邻位取代，而仅当存在甲氧基对位取代基时才容许在间位取代。这些SAR结果与在4,5,6,7-四氢噻吩并[2,3-c]吡啶系统中获得的结果相似。在酶识别中观察到对映选择性，并且该活性仅在一种对映异构体中存在于所有情况下。

  DOI：

  10.1016/s0968-0896(00)00153-x

文献信息

• Synthesis and spectral studies on Pb(II) dithiocarbamate complexes containing benzyl and furfuryl groups and their use as precursors for PbS nanoparticles
  作者：Ethiraj Sathiyaraj、Subbiah Thirumaran

  DOI：10.1016/j.saa.2012.06.052

  日期：2012.11

  alkyl chain bonded to nitrogen atom. Bis(N-benzyl-N-(2-phenylethyl)dithiocarbamato-S,S')lead(II) (3) and bis(N-furfuryl-N-(2-phenylethyl)dithiocarbamato-S,S')lead(II) (4) have been used as single source precursors for the synthesis of ethylenediamine capped PbS nanoparticles. Powder X-ray diffraction (PXRD), scanning electron microscopy (SEM), FTIR, UV-vis and fluorescence spectroscopy have been used

  已经制备了基于苄基和糠基的九种双（二硫代氨基甲酸酯）铅配合物。使用IR和NMR光谱对复合物进行表征。所有配合物在与二硫代氨基甲酸酯配体相关的（1）H和（13）C NMR光谱中均显示出预期的信号。IR和（13）C NMR光谱研究表明，S（2）CN双键特征随与氮原子相连的烷基链长度的增加而增加。双（N-苄基-N-（2-苯乙基）二硫代氨基甲酸酯-S，S'）铅（II）（3）和双（N-糠基-N-（2-苯乙基）二硫代氨基甲酸酯-S，S'）铅（ II）（4）已用作合成乙二胺封端的PbS纳米粒子的单一来源前体。粉末X射线衍射（PXRD），扫描电子显微镜（SEM），FTIR，紫外可见光谱和荧光光谱已被用于表征所制备的硫化铅纳米颗粒。PXRD测量表明，PbS纳米粒子是具有面心立方结构的单相。
• Toward Lead-Oriented Synthesis: One-Pot Version of Castagnoli Condensation with Nonactivated Alicyclic Anhydrides
  作者：Sergey V. Ryabukhin、Dmitriy M. Panov、Dmitry S. Granat、Eugeniy N. Ostapchuk、Dmitriy V. Kryvoruchko、Oleksandr O. Grygorenko

  DOI：10.1021/co4001277

  日期：2014.3.10

  One-pot variation of Castagnoli condensation, that is, reaction of cyclic anhydrides, amines, and aldehydes, has been developed as a combinatorial approach to 1,2-disubstituted 5-oxopyrrolidine- and 6-oxopiperidine-3-carboxylic acids, as well as their benzo-analogues. Utility of the method to multigram preparation of building blocks and synthetic intermediates was also demonstrated. The final products are obtained in high yields and diastereoselectivity. The method fits well in the concept of lead-oriented synthesis; in particular, it can be used for the design of lead-like Compound libraries, even if the strictest cut-offs are applied to the physicochemical properties of their members.
• Rege, Chandana M.; Gadre; Bhalekar, Satish M., Indian Journal of Heterocyclic Chemistry, 2010, vol. 20, # 2, p. 197 - 198
  作者：Rege, Chandana M.、Gadre、Bhalekar, Satish M.

  DOI：——

  日期：——
• An Efficient and Convenient Synthesis of 4,5,6,7-Tetrahydrothieno[3,2-c]pyridines by a Modified Pictet-Spengler Reaction via a Formyliminium Ion Intermediate
  作者：Yoshie Horiguchi、Michikazu Kitabatake、Aki Hashimoto、Toshiaki Saitoh、Takehiro Sano、Kunihiko Mohri

  DOI：10.3987/com-10-11992

  日期：——

  A synthesis of N-formyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridines (5) was achieved in a highly efficient manner via trifluoroacetic acid catalyzed cyclization of formyliminium ion (4), which was produced by imination of 2-(2-thienyl)ethylamine (1) and a carbonyl compound (2) using titanium(IV) tetraisopropoxide followed by formylation with acetic-formic anhydride in a one-pot procedure. This modified Pictet-Spengler reaction provides a convenient method for preparing 4,5,6,7-tetahydrothieno[3,2-c]pyridines (6) possessing various substituents at C-4.
• Fused Piperidines as a Novel Class of Potent and Orally Available Transient Receptor Potential Melastatin Type 8 (TRPM8) Antagonists
  作者：Nuria A. Tamayo、Yunxin Bo、Vijay Gore、Vu Ma、Nobuko Nishimura、Phi Tang、Hong Deng、Lana Klionsky、Sonya G. Lehto、Weiya Wang、Brad Youngblood、Jiyun Chen、Tiffany L. Correll、Michael D. Bartberger、Narender R. Gavva、Mark H. Norman

  DOI：10.1021/jm2013634

  日期：2012.2.23

  The transient receptor potential melastatin type 8 (TRPM8) is a nonselective cation channel primarily expressed in a subpopulation of sensory neurons that can be activated by a wide range of stimuli, including menthol, icilin, and cold temperatures (< 25 degrees C). Antagonism of TRPM8 is currently under investigation as a new approach for the treatment of pain. As a result of our screening efforts, we identified tetrahydrothienopyridine 4 as an inhibitor of icilin-induced calcium influx in CHO cells expressing recombinant rat TRPM8. Exploration of the structure-activity relationships of 4 led to the identification of a potent and orally bioavailable TRPM8 antagonist, tetrahydroisoquinoline 87. Compound 87 demonstrated target coverage in vivo after oral administration in a rat pharmacodynamic model measuring the prevention of icilin-induced wet-dog shakes (WDS).